PNNR

- HEARTCURE- PNRR/2022/C9/MCID/I8 - New nanotherapeutic strategies for cardiac fibrosis targeting the mechanisms underlying the fibroblast to myofibroblasttransition

- FIBROTERA PNRR/2022/C9/MCID/I8 - Targeting cardiac fibrosis in heart failure; challenges and potential solutions based on ncRNA therapeutics

- THERAGENLIV- PNRR/2022/C9/MCID/I8 - Increasing the antioxidant and endogenous cholesterol efflux potential through gene editing in fatty liver disease; preclinical studies

- IMMUNOCARD- PNRR/2022/C9/MCID/I8 - Development of a novel immunomodulatory therapy to reduce cardiac inflammation in myocardial infarction, myocarditis and sepsis

- STROMA - PNRR/2022/C9/MCID/I8 - Strengthening Romanian competence in metabolic syndrome research by exploring the role of apolipoprotein A2 in dyslipidemia, obesity and type II diabetes mellitus